Invivyd IVVD
NASDAQ IVVD
$0.83 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Invivyd (IVVD) Cash & Current Investments (2020 - 2026)

Invivyd's (IVVD) quarterly Cash & Current Investments came in at $160.1 million in Q2 2026, up 358.62% on a YoY basis from $34.9 million in Q2 2025, and down 29.38% quarter-over-quarter from $226.7 million in Q4 2025.

Analysis

Invivyd (IVVD) Cash & Current Investments (2020 - 2026) Analysis & Trends

Invivyd (IVVD) has reported Cash & Current Investments for 7 consecutive years, with $160.1 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Cash & Current Investments rose 358.62% year-over-year to $160.1 million; the trailing twelve-month figure through Jun 2026 stood at $160.1 million (up 358.62% YoY), and the FY2025 full-year result was $226.7 million, up 226.88% from the prior year.
  • Cash & Current Investments fell to $160.1 million in Q2 2026 per IVVD's latest filing, from $226.7 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $532.2 million in Q1 2022 and bottomed at $34.9 million in Q2 2025.
  • Historically, Cash & Current Investments has averaged $181.0 million across 5 years, with a median of $147.9 million in 2024.
  • The sharpest annual moves came in 2022 and 2026: Cash & Current Investments sank 83.02% in 2022, then jumped 358.62% in 2026.
  • Over 5 years, Cash & Current Investments stood at $92.1 million in 2022, then surged by 117.91% to $200.6 million in 2023, then plunged by 65.44% to $69.3 million in 2024, then jumped by 226.88% to $226.7 million in 2025, then decreased by 29.38% to $160.1 million in 2026.
  • According to Business Quant data, Cash & Current Investments over the past three periods registered $160.1 million, $226.7 million, and $85.0 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 13.99 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 3.18 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 7.85 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 7.99 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 5.18 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 5.14 Bn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 3.31 Bn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 1.29 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 1.16 Bn
10 Invivyd 244.65 Mn 84.57 Mn 13.01 Mn 160.08 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 160.08 Mn
Dec 31, 2025 226.69 Mn
Sep 30, 2025 84.97 Mn
Jun 30, 2025 34.91 Mn
Mar 31, 2025 48.08 Mn
Dec 31, 2024 69.35 Mn
Sep 30, 2024 106.87 Mn
Jun 30, 2024 147.88 Mn
Mar 31, 2024 189.39 Mn
Dec 31, 2023 200.64 Mn
Sep 30, 2023 181.82 Mn
Jun 30, 2023 121.95 Mn
Mar 31, 2023 126.47 Mn
Dec 31, 2022 92.08 Mn
Sep 30, 2022 278.15 Mn
Jun 30, 2022 474.89 Mn
Mar 31, 2022 532.22 Mn
Dec 31, 2021 542.22 Mn
Sep 30, 2021 478.27 Mn
Jun 30, 2021 392.51 Mn